clinical trials

VIDEO: Aptiv Solutions CEO Discusses Clinical Trials Guidelines, Unmet Need

February 8, 2013 OneMedPlace Team 0

Aside from re-defined financing structures, the most important issue facing life sciences EGCs is the need to increase clinical trial efficiency and productivity so that development budgets are used prudently to support products that have the best chance of market success. Speaking to OneMedTV during OneMedForum this past January, Donnelly discussed current changes that will impact the future of product development and the central role that innovative trial design will play in this.

The Briefing Room, August 24: The Week That Was in Microcap Biotech Stocks

August 27, 2012 MMargolis 0

OneMedPlace introduces a new series, “The Briefing Room”, capturing the past week’s most important developments in microcap life sciences indexes. This week, we feature Star Scientific, Kips Bay Medical, XOMA and Stellar Pharmaceuticals.

Bulls, Bears: Hot Nanocap CNS Companies

August 20, 2012 OneMedPlace Team 0

In Part II of our special report on the state of companies operating in central nervous system disease in the public markets, we look at one of the most promising nanocap companies we believe is ready to skyrocket.

Bulls, Bears: The State of CNS Companies in the Public Markets

August 15, 2012 OneMedPlace Team 0

Historically, the biotech sector has found it difficult to navigate CNS. It also has affected shareholders in numerous enterprises, with the perception that billions of investor dollars have already been wasted on overreaching and misunderstood technologies.

EpiCept’s Ceplene Product Receives Marketing Auth. by European Commission

November 29, 2011 OneMedPlace Team 0

Ceplene is administered for maintenance of first remission in patients with AML, the most common type of Leukemia in adults.

Protected: VIDEO: Talking JOBS Act with Christine Jacobs, SEC Advisory Committee Chair

August 31, 2011 OneMedPlace Team 0

There is no excerpt because this is a protected post.

Blood Tests Can Enable Early Cancer Diagnosis

November 19, 2010 Herina Ayot 0

Scientists have yet to find the magic cure for cancer, but they may have found a way to beat it at its own game.

Encouraging Fragile X Data for Seaside Therapeutics

July 27, 2010 vanderson 1

Seaside Therapeutics reported encouraging results from the largest randomized study conducted to date in patients with Fragile X syndrome.

Resverlogix to Begin Phase II Atherosclerosis Trial

December 27, 2009 vanderson 0

Canadian biopharmaceutical company Resverlogix has commenced a Phase II clinical trial for RVX-208, its small molecule therapy for the treatment of atherosclerosis in patients with stable coronary artery disease.

Cohera Receives Approval for Surgical Adhesive Trial

October 25, 2009 vanderson 0

Pittsburgh-based Cohera Medical has received approval to begin clinical trials on its TissuGlu surgical adhesive in Europe.

OneMedPlace | Blog

Just another WordPress site